Biden’s State of the Union address highlights pharma’s biggest political problem...
"Cerebral palsy can look a thousand different ways. I didn't meet someone who ac...
Can biology explain how people with the same psychiatric disorder respond differ...
Advocates are concerned that despite Biden’s strong words on reproductive health...
Biden blasted the pharmaceutical industry with its unflattering moniker, "Big Ph...
Pharma industry giants deployed a half-dozen lawyers in a bid to dismantle Medic...
This week on "The Readout LOUD": Why are addiction treatments so hard to get? Ca...
Gilead Sciences has entered an agreement with Merus for the discovery of dual tu...
The challenges and opportunities surrounding Africa becoming a clinical trials g...
The UK NICE has declined to recommend Daiichi Sankyo's Enhertu for the treatment...
Alumis secured $259m in a Series C funding round to develop its clinical-stage p...
J&J submitted a new application to the EMA for the approval of its Darzalex comb...
Discover Avacta Group's groundbreaking patent for therapeutic conjugates with ex...
AI remained one of the main talking points at CTS Europe, as the roadmap for gen...
Citius Pharmaceuticals’ CEO detailed plans to launch its lymphoma therapy Lymphi...
Sionna could have four candidates in clinical trials in 2024, amidst a cystic fi...
